**SciSparc Ltd. Announces Amended Loan Repayment Agreements with AutoMax Motors** TEL AVIV, Israel, Oct. 6, 2025 - SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company, has announced a new framework agreement regarding its financial arrangements with AutoMax Motors Ltd. As part of the agreement, the companies have mutually terminated their previous merger plans and established clear terms for the repayment of outstanding loans. Under the new agreement, AutoMax will repay a $4.25 million loan from SciSparc in a single lump-sum payment, including 9% annual interest, by January 1, 2028. In addition, a separate $2 million loan will be repaid in monthly installments of $60,000 starting November 20, 2025, with 8% annual interest. Accrued interest of approximately $114,523 on the second loan will be paid upfront. The agreement formalizes the repayment structure and resolves previous commitments between the companies.